RESUMEN
Aberrant crypt foci (ACF) have been proposed as intermediate biomarkers for colon carcinogenesis on the basis of many rodent studies. Although molecular analyses have indicated that these lesions in experimental animals are related to early events in colon carcinogenesis, their preneoplastic nature has yet to be fully elucidated. In the present study, one hundred and thirty 19-week-old male Fischer 344 rats were examined. The biological characteristics of spontaneous ACF were analyzed histopathologically, immunohistochemically and with molecular biological techniques, and compared with colon tumors found in control groups used for carcinogenicity tests. The incidences of spontaneous ACF consisting of 1, 2, 3 and 4 or more crypts were respectively 27.7%, 32.5%, 16.8% and 22.8%. Most ACF were distributed in the lower middle and upper distal colon, and proximal colon ACF was rare. Likewise, ACF frequently (42.5%) developed in untreated animals, whereas the incidence of spontaneous colorectal tumors was extremely low (0.68%) in control male rats. In addition, spontaneous ACF did not show apparent proliferative activity or c-K-ras point mutations. Our results thus suggest that spontaneous ACF rarely progress to colon tumors although long-term sequential observation might be necessary to conclude the significance of ACF.
Asunto(s)
Adenocarcinoma/patología , Adenoma/patología , Colon/patología , Neoplasias del Colon/patología , Lesiones Precancerosas/patología , Adenocarcinoma/genética , Adenoma/genética , Animales , Colon/efectos de los fármacos , Neoplasias del Colon/genética , Femenino , Genes ras/genética , Mucosa Intestinal/patología , Masculino , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo Conformacional Retorcido-Simple , Ratas , Ratas Endogámicas F344RESUMEN
The chronic toxicity of josamycin was examined in Fischer 344 (F344) rats. Groups of 10 males and 10 females were given the test compound in the diet at concentrations of 0 (control), 0.02, 0.1, 0.5 or 2.5% for 52 weeks. Daily intake of josamycin was 0, 10, 50, 260 and 1310 mg/kg body weight in males and 0, 10, 60, 290 and 1460 mg/kg body weight in females, respectively. Body weight gain was significantly (P<0.05) reduced in the male 2.5% group but no noticeable changes were found in food intake. In hematological examination, the platelet count was significantly (P<0.01) lower in the male groups given 0.02% or more of josamycin and in the 2.5% female group as compared with the control group values in a dose-dependent manner. In serum biochemical examination, blood urea nitrogen was significantly (P<0.05 and P<0.01, respectively) higher in males given 0.5 and 2.5% and total bilirubin was significantly (P<0.05) higher in females receiving 2.5% as compared with those of the control group. No death occurred at any dose levels during the dosing period. At necropsy, with the exception of cecal enlargement in the groups given more than 0.1% josamysin and a significant (P<0.01) increase in the relative liver weight of females in the 2.5% group, no particular findings related to the administration were observed. Histopathologically, the incidence and severity of liver bile duct proliferation in female 2.5% group were significantly (P<0.01) greater than those of the control group. Other histological changes found in the treated and control groups were similar to the spontaneous lesions in this strain of rats in terms of the incidence and severity. Interestingly, the josamycin treatment reduced the development of altered liver cell foci in females in a dose-dependent manner. Thus, it is concluded that, under the present experimental conditions, josamycin induces bile duct proliferation in female F344 rats at a high dose of 1460 mg/kg body weight. Based on the decrease of platelet count found in males given 10 mg/kg body weight or more, the no-observed-adverse-effect level (NOAEL) was estimated to be less than 10 mg/kg body weight.
Asunto(s)
Antibacterianos/toxicidad , Josamicina/toxicidad , Animales , Femenino , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Endogámicas F344RESUMEN
Aberrant crypt foci (ACFs) in the Fischer 344 (F344) rat colon, of control or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-treated groups, were compared morphologically, immunohistochemically, and at the molecular biological level in order to elucidate their biological characteristics. Male 3-week-old rats were fed a diet supplemented with or without MeIQx at doses of 100 ppm or less for 16 weeks. The incidence of ACFs was the highest (90%) in animals given 100 ppm MeIQx but that in untreated rats was also surprisingly high (57%). Nine ACFs from nine MeIQx-treated rats and ten ACFs from ten untreated control rats were selected for detailed examination for their large size. There were no morphological differences in macroscopic and microscopic features between MeIQx-promoted and spontaneous ACFs. There were also no differences in immunohistochemical labeling for proliferating cell nuclear antigen (PCNA) and p53 protein between these ACFs although in both cases labeling was higher than in normal crypts. Dot blot hybridization revealed no c-K-ras mutations in codon 12 except in one ACF (11.1%) developing in a rat treated with 100 ppm MeIQx, in which a GGT-->GAT single base substitution was detected. Our results thus suggest that in terms of morphology, cell proliferation, P53 expression and c-K-ras mutation, most ACFs found in rats given 100 ppm MeIQx are essentially identical to their spontaneous counterparts.
Asunto(s)
Carcinógenos/toxicidad , Neoplasias del Colon/inducido químicamente , Mutágenos/toxicidad , Lesiones Precancerosas/inducido químicamente , Quinoxalinas/toxicidad , Animales , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Genes ras , Masculino , Mutación , Lesiones Precancerosas/genética , Lesiones Precancerosas/patología , Antígeno Nuclear de Célula en Proliferación/análisis , Ratas , Ratas Endogámicas F344 , Proteína p53 Supresora de Tumor/análisisRESUMEN
The chemopreventive influence of phenethyl isothiocyanate (PEITC) during the post-initiation stage was investigated in the N-nitrosobis(2-oxopropyl)amine (BOP)-initiated hamster tumorigenesis model. A total of 120 female 5-week-old hamsters were divided into six groups. Animals in groups 1-3, each consisting of 30 hamsters, were injected twice, subcutaneously, with BOP 7 days apart to effect initiation. Starting 1 week after the second BOP injection, hamsters in groups 1 and 2 were fed diets supplemented with 6 micromol/g and 3 micromol/g of PEITC, respectively, for 51 weeks. Animals in group 3 received a basal diet as an initiation positive control. Animals in groups 4-6, each consisting of ten hamsters, were given 6 micromol/g or 3 micromol/g of PEITC alone, or were non-treated, matched negative controls for groups 1-3. At the termination of experimental week 52, the incidences and multiplicities of neoplastic lesions in the target organs including the pancreas, lung, liver and kidney were found to be comparable among the BOP-treated groups. The values for pancreatic adenocarcinomas as well as dysplastic lesions tended to increase although without statistical significance. Taken together with our previous finding that PEITC dramatically inhibited the initiation phase of BOP-induced pancreatic and lung tumorigenesis in hamsters, it can be concluded that PEITC specifically exerts chemopreventive effects only when given concomitantly with the carcinogen.
Asunto(s)
Adenocarcinoma/prevención & control , Anticarcinógenos/administración & dosificación , Isotiocianatos/administración & dosificación , Neoplasias Experimentales/prevención & control , Adenocarcinoma/inducido químicamente , Animales , Peso Corporal/efectos de los fármacos , Pruebas de Carcinogenicidad , Cricetinae , Suplementos Dietéticos , Femenino , Neoplasias Renales/inducido químicamente , Neoplasias Renales/prevención & control , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/prevención & control , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/prevención & control , Neoplasias Experimentales/inducido químicamente , Nitrosaminas , Neoplasias Pancreáticas/inducido químicamente , Neoplasias Pancreáticas/prevención & controlRESUMEN
In order to examine the influences by long-term feeding of 24R, 25 dihydroxyvitamin D3[24R, 25(OH)2D3], an active form of vitamin D, Wistar rats (14-week-old, male, 20 rats/group) were fed a powder diet containing 0 or 5 ppm 24R, 25(OH)2D3 for 57 weeks. Final body weights and total food consumption were comparable between the groups. Urinary calcium levels were significantly (p < 0.05 or 0.01) increased by the administration of 24R, 25(OH)2D3 at weeks 3, 22 and 56, although the levels of serum calcium did not differ between the groups at the termination of week 57. In the 24R, 25(OH)2D3 group, weights of the adrenals and femurs were significantly (p < 0.01) increased. Histopathologically, this was found due to thickening of cortical bone in the femurs, and medullary hyperplasia and pheochromocytoma of the adrenals. Immunohistochemically, proliferating cell nuclear antigen (PCNA)-labeling indices for intact adrenal medulla, medullary hyperplasia and pheochromocytoma in the 24R, 25(OH)2D3 group were respectively 1.82 +/- 1.21, 5.88 +/- 4.13 and 16, all higher than that for the adrenal medulla in the control group (0.87 +/- 0.67). These results indicate that 24R, 25(OH)2D3 at a dose with which serum calcium is not chronically increased causes thickening of the cortex of the femur, and development of adrenal proliferative lesions, suggesting that rats may be too sensitive for results to be relevant to human risk assessment.
Asunto(s)
24,25-Dihidroxivitamina D 3/toxicidad , Médula Suprarrenal/efectos de los fármacos , Calcio/metabolismo , Corteza Suprarrenal/patología , Neoplasias de las Glándulas Suprarrenales/inducido químicamente , Glándulas Suprarrenales/efectos de los fármacos , Médula Suprarrenal/patología , Animales , Apetito/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Calcio/sangre , Calcio/orina , Fémur/efectos de los fármacos , Fémur/patología , Hiperplasia , Masculino , Tamaño de los Órganos/efectos de los fármacos , Feocromocitoma/inducido químicamente , Fósforo/orina , Ratas , Ratas WistarRESUMEN
The modifying effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a mutagenic by-product in chlorinated water, on the development of glandular stomach cancers were investigated in Wistar rats. A total of 120 males, 6 weeks of age, were divided into six groups. After initiation with 100 ppm N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) solution and 5% NaCl diet for 8 weeks, 30 rats each in groups 1-3 were given MX in the drinking water at concentrations of 30, 10, or 0 ppm for the following 57 weeks. Ten animals each in groups 4-6 were administered the MX without prior carcinogen exposure. There were no statistical significant differences in final body weights between the groups. The incidences and multiplicities of adenocarcinomas in the glandular stomachs were significantly higher (P < 0.05) in the initiated 30 ppm MX group than those in the MNNG/NaCl group. The incidences of atypical hyperplasias in the glandular stomachs were also significantly increased (P < 0.05 or 0.01) by the MX treatments. With their multiplicity, the effects were clearly dose dependent. Interestingly, the 30 ppm MX alone itself induced atypical hyperplasias in the pylorus, although the incidences and severity were low. Moreover, MX showed a tendency to enhance the development of intrahepatic cholangiocellular tumors and thyroid follicular cell tumors in the MNNG-treated animals. The results of the present study thus indicate that MX exerts promoting effects when given during the postinitiation phase of two-stage glandular stomach carcinogenesis in rats.
Asunto(s)
Adenocarcinoma/inducido químicamente , Carcinógenos/toxicidad , Furanos/toxicidad , Metilnitronitrosoguanidina/toxicidad , Mutágenos/toxicidad , Neoplasias Gástricas/inducido químicamente , Contaminantes Químicos del Agua/toxicidad , Adenocarcinoma Folicular/inducido químicamente , Adenoma de los Conductos Biliares/inducido químicamente , Animales , Neoplasias de los Conductos Biliares/inducido químicamente , Conductos Biliares Intrahepáticos/efectos de los fármacos , Conductos Biliares Intrahepáticos/patología , Peso Corporal/efectos de los fármacos , Colangiocarcinoma/inducido químicamente , Cocarcinogénesis , Fibrosis , Hiperplasia , Masculino , Tamaño de los Órganos/efectos de los fármacos , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/patología , Píloro/efectos de los fármacos , Píloro/patología , Ratas , Ratas Wistar , Estómago/efectos de los fármacos , Estómago/patología , Gastropatías/inducido químicamente , Gastropatías/patología , Neoplasias de la Tiroides/inducido químicamenteRESUMEN
The carcinogenicity of josamycin was examined in Fischer 344 (F344) rats. Groups of 50 males and 50 females were given the compound in their diet at concentrations of 0 (control), 1.25 or 2.5% for 104-weeks; these dose levels were selected on the basis of the results of a subchronic study, in which animals rather rejected 5% josamycin. All surviving rats were killed at wk 106. A variety of tumours developed in all groups, including the control group, but all the neoplastic lesions were histologically similar to those known to occur spontaneously in this strain of rats, and no statistically significant increase in the incidence of any tumour was found in the treated groups of either sex. Interestingly, the josamycin treatment significantly reduced the development of altered liver cell foci and chronic nephropathy in a dose-dependent manner. Thus, it was concluded that, under the present experimental conditions, josamycin is not carcinogenic in F344 rats.
Asunto(s)
Antibacterianos/toxicidad , Josamicina/toxicidad , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Neoplasias/inducido químicamente , Animales , Antibacterianos/administración & dosificación , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Corazón/efectos de los fármacos , Incidencia , Josamicina/administración & dosificación , Riñón/patología , Hígado/patología , Masculino , Neoplasias/epidemiología , Tamaño de los Órganos/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Endogámicas F344RESUMEN
The effects of administration of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a tobacco-specific nitrosamine, were investigated in hamsters treated with N-nitrosobis(2-oxopropyl)amine (BOP). Female Syrian golden hamsters were given a single sc injection of BOP at a dose of 10 mg/kg and then administered 2 or 5 ppm NNAL in their drinking water for 52 wk. Additional groups of animals received the BOP injection alone, or only the 2 or 5 ppm NNAL treatments as BOP-negative controls. At wk 53 of the experiment, all surviving animals were killed and the development of proliferative lesions was assessed histopathologically. The total incidence of combined carcinomatous and dysplastic lesions of the exocrine pancreas was significantly higher (P < 0.05) in the BOP/NNAL 5 ppm group than in the BOP alone group, although there was no statistically significant influence of NNAL on the development of either pancreatic adenocarcinomas or dysplastic lesions viewed singly. The treatments with NNAL alone did not induce any proliferative lesions of the exocrine pancreas. No significant intergroup differences were found in either incidence or multiplicity of islet cell proliferative lesions. Immunohistochemical examination of islet cell proliferative lesions (hyperplasias and adenomas) found in the BOP-treated animals showed no significant differences in pancreatic hormone production between NNAL-treated and -untreated groups. The NNAL treatment did not exert any influence on lung, liver or kidney tumorigenesis. Thus, the results suggest that NNAL enhances BOP-induced exocrine but not endocrine pancreatic tumorigenesis in hamsters when given in the post-initiation phase.
Asunto(s)
Nitrosaminas/toxicidad , Neoplasias Pancreáticas/inducido químicamente , Animales , Carcinógenos , División Celular/efectos de los fármacos , Cricetinae , Ingestión de Líquidos/efectos de los fármacos , Interacciones Farmacológicas , Femenino , Inmunohistoquímica , Islotes Pancreáticos/química , Islotes Pancreáticos/efectos de los fármacos , Islotes Pancreáticos/patología , Hígado/efectos de los fármacos , Hígado/patología , Pulmón/efectos de los fármacos , Pulmón/patología , Mesocricetus , Páncreas/efectos de los fármacos , Páncreas/patología , Neoplasias Pancreáticas/patología , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/patologíaRESUMEN
2-Amino-3,8-dimethylimidazo[4, 5-f]quinoxaline (MeIQx), a heterocyclic amine found in cooked meats, is carcinogenic in mice and rats at high doses. In order to examine the toxicity including preneoplastic changes at the lower doses, a total of 170 male Fischer 344 rats were administered MeIQx for 16 weeks at a dose of 100, 10, 1, 0.1, 0.01, 0.001 ppm or 0 ppm in the diet. The numbers of GST-P positive foci and BrdU-labeling indices in the liver were significantly increased by the dietary administration of 10 ppm and 1 ppm or more of MeIQx respectively, when compared with the basal diet-fed control rats. Aberrant cry p tfoci (ACF) were also significantly increased in the 100 ppm MeIQx group as compared to the control value. No histopathological changes indicating obvious toxicity of MeIQx were observed in the major organs other than the liver and large intestine. In conclusion, our results clearly indicate that MeIQx selectively targets the liver and large intestine of rats as organs for the toxicity, but dose not affect the other major organs at low doses.
Asunto(s)
Carcinógenos , Quinoxalinas/toxicidad , Animales , Dieta , Intestinos/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas F344RESUMEN
The modifying effects of alpha-difluoromethylomithine (DFMO) on glandular stomach carcinogenesis after initiation with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and sodium chloride were investigated in male outbred Wistar rats. Animals were simultaneously given MNNG solution (100 ppm) as their drinking water and diet supplemented with 10% sodium chloride for 8 weeks, and administered DFMO (dietary levels of 2000 ppm or 500 ppm) and tap water for the following 70 weeks. The DFMO treatment did not show any tendency to inhibit the development of gastric adenocarcinomas. The incidences and multiplicities of atypical hyperplasias in the glandular stomachs were also comparable in all groups of rats given MNNG/sodium chloride. Neither gastric carcinomas nor atypical hyperplasias were observed without the carcinogen treatment. Thus, DFMO did not exert any inhibitory effects when given during the post-initiation phase of two-stage glandular stomach carcinogenesis in rats initiated with MNNG and sodium chloride for 8 weeks.
Asunto(s)
Adenocarcinoma/prevención & control , Eflornitina/uso terapéutico , Neoplasias Gástricas/prevención & control , Animales , División Celular/efectos de los fármacos , Quimioprevención , Masculino , Metilnitronitrosoguanidina , Ratas , Ratas Wistar , Cloruro de SodioRESUMEN
The long-term toxicity and carcinogenicity of histidine, an essential amino acid for most animal species, were examined in Fischer 344 (F344) rats. Groups of 50 males and 50 females were given L-histidine monohydrochloride (HMHC) in their diet at concentrations of 0 (control), 1.25 and 2.5% for 104 wk; these dose levels were selected on the basis of the results of a subchronic toxicity study, in which body weights were depressed and formation of sperm granulomas in the epididymis was histologically evident in males fed 5.0% HMHC. All surviving rats were killed at wk 107. Increases in red blood cell count, haemoglobin value and haematocrit level were observed in male rats given 2.5% HMHC. A variety of tumours developed in all groups, including the control group, but all the neoplastic lesions were histologically similar to those known to occur spontaneously in this strain of rats, and no statistically significant increase in the incidence of any tumor was found in the treated groups of either sex. Thus, it was concluded that, under the present experimental conditions, HMHC is not carcinogenic in F344 rats.
Asunto(s)
Histidina/toxicidad , Administración Oral , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/crecimiento & desarrollo , Animales , Recuento de Células Sanguíneas/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/crecimiento & desarrollo , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Femenino , Histidina/administración & dosificación , Pulmón/efectos de los fármacos , Pulmón/crecimiento & desarrollo , Masculino , Neoplasias/inducido químicamente , Tamaño de los Órganos/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Endogámicas F344 , Organismos Libres de Patógenos Específicos , Aumento de Peso/efectos de los fármacosRESUMEN
The chemopreventive effects of phenethyl isothiocyanate (PEITC) were investigated in N-nitrosobis(2-oxopropyl)-amine (BOP)-treated hamsters. Female 5-week-old Syrian golden hamsters were divided into six groups. Animals in groups 1-3, each consisting of 30 hamsters, were given BOP by two subcutaneous injections 7 days apart at a dose of 20 mg/kg body weight, plus either 100, 10 or 0 micromol of PEITC in corn oil by gavage 2 h prior to each BOP treatment, respectively per group. Animals in groups 4 and 5, each consisting of 10 hamsters, were given 100 and 10 micromol of PEITC alone in corn oil, and 10 animals in group 6 served as a vehicle control. Animals were sacrificed 52 weeks after the first BOP injection. Both the incidences and multiplicities of lung adenomas and/or adenocarcinomas were significantly decreased in a dose-dependent manner by PEITC treatments (P < 0.01 or 0.05). The lung tumor incidences were inhibited by 100% with 100 micromol PEITC and by 82% with the 10 micromol dosage. In addition, the high dose of PEITC also significantly inhibited pancreatic carcinogenesis (P < 0.05) and showed a tendency to lower the incidences of liver and renal tumors, although these effects were not statistically significant. Under the present experimental conditions, PEITC itself did not cause any apparent toxicity. Our results thus indicate that PEITC is a remarkably effective chemopreventive agent for the BOP-induced lung and pancreatic tumors in hamsters.
Asunto(s)
Adenocarcinoma/prevención & control , Anticarcinógenos/uso terapéutico , Isotiocianatos/uso terapéutico , Neoplasias Pulmonares/prevención & control , Neoplasias Pancreáticas/prevención & control , Adenocarcinoma/inducido químicamente , Animales , Peso Corporal/efectos de los fármacos , Carcinógenos , Cricetinae , Femenino , Neoplasias Pulmonares/inducido químicamente , Mesocricetus , Nitrosaminas , Neoplasias Pancreáticas/inducido químicamenteRESUMEN
The chemopreventive effects of 3-phenylpropyl isothiocyanate (PPITC) were investigated in N-nitrosobis(2-oxopropyl)amine (BOP)-initiated hamsters. A total of 120 female 5-week-old hamsters were divided into 6 groups. Animals in groups 1-3, each consisting of 30 hamsters, were twice sc injected 7 days apart as an initiation treatment. Hamsters in groups 1 and 2 were respectively given 100 microM and 10 microM of PPITC by gavage 2 h prior to each BOP treatment. Animals in group 3 were treated with BOP alone, serving as an initiation-positive control. Animals in groups 4-6, each consisting of 10 hamsters, were given 100 microM or 10microM of PPITC alone, or non-treated, thus being available as matched negative controls to groups 1-3. At termination (experimental week 51 after the first BOP injection), the incidences of lung adenomas and/or adenocarcinomas were significantly decreased in groups 1 and 2 as compared to the group 3 value (p<0.01). The combined lung tumor incidences were inhibited by 94% and 59% at 100 and 10 microM doses, respectively. The inhibitory effects of PPITC were thus dose-dependent. The data for multiplicity of lung tumors dramatically illustrated the inhibitory effects of PPITC, and there were also statistically significant differences in the chemopreventive effect between 100 microM and 10 microM PPITC treatments. On the other hand, the PPITC treatments did not significantly modulate the development of neoplastic lesions in the pancreas,liver and kidney, although the treatments did show inhibitory tendencies, except on the liver lesions. Under present experimental conditions, PPITC itself did not exhibit tumorigenicity or apparent toxicity. The results in the present study thus clearly indicate that PPITC has an effective chemopreventive action on BOP-induced lung tumorigenesis in hamsters.
Asunto(s)
Isotiocianatos/farmacología , Neoplasias Pulmonares/inducido químicamente , Nitrosaminas/antagonistas & inhibidores , Animales , Peso Corporal/efectos de los fármacos , Cricetinae , Femenino , Neoplasias Renales/inducido químicamente , Neoplasias Hepáticas/inducido químicamente , Mesocricetus , Tamaño de los Órganos/efectos de los fármacos , Neoplasias Pancreáticas/inducido químicamenteRESUMEN
A 13-week oral toxicity study of gardenia blue was performed in male and female F344 rats at the dose levels of 5.0, 2.5, 1.25, 0.6 and 0% in the diet, to determine the maximum tolerable dose (MTD) for subsequent investigation of carcinogenicity. Rats were randomly allocated to 5 groups, each consisting of 10 males and 10 females. No groups showed decreases in body weight gain and food intake, and all animals survived until the end of the experiment. A dose-dependent decrease in number of platelets was observed in females treated with gardenia blue in hematological examination, but not in males. No histopathological change, relating to the treatment, in megakaryocyte which is the progenitor cell of platelets was observed in the treated-females. Serum biochemistry revealed increases in GOT and GPT in both sexes treated with the 5.0% and 2.5% gardenia blue, as compared to the control value. However, these were not considered to be specific changes because of lack of any clear dose response. In addition, no histopathological changes indicating obvious toxicity of gardenia blue were observed in the liver of both sexes treated with gardenia blue. Based on these data, the MTD of gardenia blue for both sexes in F344 rats was considered to be 5.0% or more in the diet.
Asunto(s)
Colorantes de Alimentos/toxicidad , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Femenino , Hígado/efectos de los fármacos , Masculino , Megacariocitos/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Endogámicas F344 , Factores de TiempoRESUMEN
To assess the optimal dosing period and parameters for measurement of effects on male fertility, Compound T was administered to male Jcl:Wistar rats at dosage levels of 0, 2, 10 and/or 50 mg/kg/day for 4 weeks (Experiment 1) or for 9 weeks (Experiment 2). Experiment 1: In the 50 mg/kg group, the ventral prostate weight was low when compared to the control value, and desquamation of round spermatids was observed in the testes. Experiment 2: When treated males were mated with untreated females after dosing for 9 weeks (the first mating), the fertility index was slightly lowered and preimplantation loss was significantly elevated in the 50 mg/kg group as compared to the control values. In this treatment group, serum testosterone level at 2.5 hours after dosing was significantly decreased after dosing for 12 weeks, and degeneration of spermatids/spermatocytes in the testis and epididymis was observed after dosing for 13 weeks. After a recovery period of for 6 weeks, remating resulted in copulatory and fertility indices and cesarean section data which were comparable in all groups. In conclusion, there were no differences in toxicity relevant to male fertility between 4 and 9 weeks of dosing, and it is considered that the observed changes resulted from decreased function of Sertoli cells due to depressed production/secretion of testosterone.
Asunto(s)
Fertilidad/efectos de los fármacos , Genitales Masculinos/efectos de los fármacos , Infertilidad Masculina/inducido químicamente , Infertilidad Masculina/diagnóstico , Nootrópicos/administración & dosificación , Nootrópicos/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Genitales Masculinos/patología , Masculino , Nootrópicos/sangre , Ratas , Ratas WistarRESUMEN
To investigate age-related changes in visual function in rats, male and female Fischer 344 (F344) rats at 30 months of age were examined electrophysiologically and histopathologically. The selection rate for the dark area in a T-shaped test box was 80% in aged rats, and the ability of light-dark discrimination was definitely depressed. Electroretinogram (ERG) was non-recordable in 25 out of the 28 eye balls examined, and amplitudes of the ERG a- and b-waves were markedly depressed in the remaining three eye balls. Histopathologic examination of the retina revealed marked atrophy of photoreceptor cells on the outer nuclear and photoreceptor layers; the change was less extensive in the retina of eye balls in which ERG was recordable. Immunohistochemically, increased reactivity to anti-glial fibrillary acid protein serum was observed in the retina of the aged animals. These results evidenced that the number of photoreceptor cells is decreased in age F344 rats, resulting in the reduced reactivity to light and the depressed light-dark discrimination.